SynAct Pharma AB

kr 15.28As of Sun 8 Nov 2026, 12:00 UTC
STO:SYNACTHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR 9.13%
Div yield —
ROE (60.95%)
Biotechnology
Beta (5Y) 0.83
PE TTM —
TSR TTM (36.86%)
Mkt cap kr 855.7M
ROIC (35.08%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 16
6.03%
(88.70%)
Hold 5|4|6|12|12
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.17
0.17
0.19
0.18
10.91%
12.64%
15.93%
3.69%
Revenuekr M
53.02
53.36
56.55
57.55
4.24%
5.43%
9.85%
13.73%
Peers (US$86.51M)
Cap (US$)
PE
85.32M
22.67x
75.71M
—
Capital
TTM
5Y
10Y
Leveragex
0.432
—
(0.013)
EBIT/Intx
0.430
0.280
0.298
Own earn%
(50.45)
(63.17)
(65.37)
Sh yield%
25.98
40.20
38.52
Owners
Insiders/Inst%
11.79
66.20
Short interest%
0.77
SBC / revenue%
0.73
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
11–18
$1 testx
−0.1
Incr. ROIC%
1